v
Search
Advanced

Publications > Journals > Most Viewed Articles

Results per page:
v
Original Article Open Access
Zixuan Ma, Junfeng Feng
Published online September 28, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 1038
Neurosurgical Subspecialties. doi:10.14218/NSSS.2026.00026
Abstract
Watertight-intent dural reconstruction may reduce incisional cerebrospinal fluid (CSF) leakage after decompressive craniectomy but may prolong surgery. We aimed to evaluate whether [...] Read more.

Watertight-intent dural reconstruction may reduce incisional cerebrospinal fluid (CSF) leakage after decompressive craniectomy but may prolong surgery. We aimed to evaluate whether watertight-intent reconstruction, compared with non-watertight management, was associated with direct postoperative incisional CSF leakage and operative time.

Five databases were searched through August 1, 2026. Comparative studies with explicit watertight or sealing-intent reconstruction and non-watertight comparators were included. The primary outcome was direct incisional CSF leakage; secondary outcomes included operative time, wound or surgical-site infection, hydrocephalus, mortality, and functional outcomes. Binary outcomes were expressed as risk ratios (RRs), and continuous outcomes as mean differences. Random-effects meta-analysis used restricted maximum likelihood estimation with Wald 95% confidence intervals (CIs); randomized and observational studies were examined as subgroups, with Hartung–Knapp sensitivity analyses. Certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation framework.

Twelve studies were included; nine (1,314 participants) reported direct incisional CSF leakage. Watertight-intent reconstruction was associated with fewer reported leaks (RR, 0.54; Wald 95% CI, 0.34–0.86; I² = 23.3%), although the prediction interval included the null value (0.24–1.20). The randomized subgroup was imprecise (RR, 0.75; 95% CI, 0.32–1.73), whereas the observational subgroup favored reconstruction (RR, 0.43; 95% CI, 0.20–0.90); its Hartung–Knapp interval (0.14–1.32) crossed 1. Infection and hydrocephalus estimates were imprecise; mortality and function were not pooled. Reconstruction was associated with longer operative time (mean difference, 39.85 minutes; 95% CI, 25.14–54.56; I² = 97.4%). Certainty was very low for all key outcomes.

Watertight-intent reconstruction is associated with fewer reported incisional CSF leaks and longer operations, although certainty is very low. Limited study and event numbers, imprecise design subgroups, and multicomponent techniques preclude causal or universal treatment conclusions. Effects on infection, hydrocephalus, mortality, and function remain uncertain.

Full article
Review Article Open Access
Shengnan Kong, Lin Chen, Haojia Lyu, Qin Lai, Xinya Li, Yu Wang, Jun Lyu
Published online September 28, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 1026
Journal of Translational Critical Care Medicine. doi:10.14218/JTCCM.2026.00011
Abstract
Large-scale critical care databases have expanded opportunities for clinical research. Previous reviews have summarized open-access intensive care unit databases and specific analytical [...] Read more.

Large-scale critical care databases have expanded opportunities for clinical research. Previous reviews have summarized open-access intensive care unit databases and specific analytical methods, but integrated, practice-oriented guidance on commonly used and emerging methods and their selection remains limited. The objective of this narrative review is to provide a practice-oriented overview of commonly used and emerging statistical and modeling methods in critical care database research, with emphasis on their appropriate applications, strengths, limitations, and considerations for method selection. This narrative review summarizes commonly used and emerging methods in critical care database research, focusing on their applications, strengths, limitations, and practical considerations. The methods reviewed range from descriptive and regression analyses to prediction modeling, longitudinal analysis, causal inference, and artificial intelligence-based approaches. Common problems include missing data, temporal bias, confounding, overfitting, and limited external validation. Careful method selection and appropriate validation are therefore important when working with complex critical care data. Closer coordination of clinical questions, data structures, analytical methods, and reporting standards can strengthen research using intensive care unit databases. Paying closer attention to data quality, causal hypotheses, validation, reproducibility, and generalizability may improve the methodological rigor and translational value of these studies.

Full article
Research Letter Open Access
Sadaf Barakzoy, Elie Farha, Alexandre Sayadi, Mylène Sebagh, Eric Vibert, Marc Antoine Allard
Published online September 29, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 1003
Journal of Clinical and Translational Hepatology. doi:10.14218/JCTH.2026.00399
Opinion Open Access
Leo Nnamdi Ozurumba-Dwight
Published online September 28, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 988
Gene Expression. doi:10.14218/GE.2026.00028
Review Article Open Access
Guozirui Mou, Jingnan Xiong, Liyuan Chen, Manni Tan, Yina Ma, Taduoji Ze, Xia Li, Hongyun Zhao
Published online October 29, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 977
Journal of Clinical and Translational Hepatology. doi:10.14218/JCTH.2026.00396
Abstract
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a rapidly increasing global health concern, driven by metabolic stress, chronic inflammation, and progressive [...] Read more.

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a rapidly increasing global health concern, driven by metabolic stress, chronic inflammation, and progressive fibrotic remodeling. Myeloid-derived suppressor cells (MDSCs) have emerged as pivotal yet context-dependent modulators of MAFLD pathogenesis. This review summarizes the biological characteristics of MDSCs, their immunosuppressive mechanisms, and their multifaceted roles in MAFLD progression, including hepatic steatosis, chronic inflammation, and fibrogenesis. Quantitative synthesis reveals that murine models demonstrate MDSC expansion (∼3-fold with a high-fat diet, P < 0.05) and suppression of MDSC-associated proinflammatory mediators (e.g., MitoTEMPO reduced hepatic S100A8 mRNA by 5.9-fold, P < 0.001). In one human cohort (n = 98), hepatic CD33+/HLA-DR− MDSC density correlated with inflammation grade (Spearman r = 0.610, P < 0.001) and fibrosis stage (r = 0.687, P < 0.001), though this cross-sectional dataset lacked MAFLD-specific stratification and longitudinal validation. We further discuss emerging MDSC-targeted strategies and explicitly acknowledge current translational gaps. Collectively, this review provides a mechanistic and critically appraised framework positioning MDSCs as both promising therapeutic targets and potential biomarkers for MAFLD.

Full article
Review Article Open Access
Ramesh Kumar, Shalimar, Ruchika Narayan, Sudhir Kumar
Published online October 27, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 974
Journal of Clinical and Translational Hepatology. doi:10.14218/JCTH.2026.00495
Abstract
Ascites is the most frequent complication of cirrhosis, signaling the transition from compensated to decompensated liver disease. While traditionally linked to portal hypertension, [...] Read more.

Ascites is the most frequent complication of cirrhosis, signaling the transition from compensated to decompensated liver disease. While traditionally linked to portal hypertension, arterial vasodilation, and renal sodium retention, previous research has broadened our understanding of its pathophysiology. The hepatic and splanchnic lymphatic systems are increasingly recognized as potential contributors to decompensation in cirrhosis. The elevated sinusoidal pressure in cirrhosis markedly increases lymph production, which is initially compensated by expanded lymphatics and lymphangiogenesis. However, progressive cirrhosis impairs lymphatic function by inducing abnormal lymphangiogenesis, vessel dilation, and poor contractility, which collectively reduce drainage. When lymph overproduction exceeds the maximum drainage capacity of the lymphatic system, the fluid leaks through the subcapsular lymphatics, leading to leakage of protein-rich lymph through the liver surface into the peritoneal cavity—a phenomenon often referred to as a “weeping liver.” The osmotic gradient of this protein-rich fluid, combined with hydrostatic pressures and lymphatic failure, may draw additional fluid from the splanchnic circulation and contribute to ascites development and progression. Simultaneously, dysfunction of the gut-splanchnic lymphatic axis may promote intestinal edema, bacterial translocation, and systemic inflammation, thereby reinforcing portal hypertension and contributing to downstream manifestations such as intestinal lymphangiectasia and refractory ascites. Yet, despite its pathophysiological relevance, the contribution of lymphatic failure to the complications of cirrhosis remains widely underappreciated. Recognizing this critical axis may help identify novel therapeutic targets in patients with cirrhosis. This review provides a detailed overview of lymphatic failure as a contributor to altered fluid dynamics and secondary complications in cirrhosis, offering a contextual evaluation of its therapeutic implications.

Full article
Review Article Open Access
Hao Li, Xianglin Meng
Published online September 30, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 967
Journal of Translational Critical Care Medicine. doi:10.14218/JTCCM.2026.00002
Abstract
Despite the 2012 Berlin definition standardizing acute respiratory distress syndrome (ARDS) diagnosis, pharmacological therapies have consistently failed in phase 3 trials, partly [...] Read more.

Despite the 2012 Berlin definition standardizing acute respiratory distress syndrome (ARDS) diagnosis, pharmacological therapies have consistently failed in phase 3 trials, partly reflecting the syndrome’s profound biological heterogeneity. We synthesize evidence on ARDS subphenotyping to evaluate prospects for precision medicine. This narrative review was informed by targeted searches of PubMed/MEDLINE, Embase, and Web of Science from database inception through February 2026, supplemented by an updated PubMed/MEDLINE search through September 2026. Representative clinical trials, multicenter cohorts, mechanistic studies, and methodological reports were selected to support a critical synthesis of ARDS subphenotyping, its therapeutic implications, and barriers to clinical translation. Hyperinflammatory and hypoinflammatory subphenotypes—originally identified using plasma biomarkers (IL-6, IL-8, and soluble tumor necrosis factor receptor 1) in the ARMA and ALVEOLI cohorts—demonstrate reproducible differences in mortality, with worse outcomes in the hyperinflammatory subphenotype, and have shown potential treatment-effect heterogeneity in secondary analyses. Approximately 30%–35% of patients exhibit the hyperinflammatory profile, characterized by greater vasopressor requirements and organ failure. Radiological phenotypes (focal versus non-focal) on computed tomography imaging have been associated with differences in lung recruitability and physiological responses to ventilatory interventions, although the LIVE trial did not demonstrate an overall survival benefit from morphology-guided ventilation. Recent multi-omics studies (transcriptomic, proteomic, and metabolomic) reveal distinct endotypes involving dysregulated innate immunity, endothelial activation, and aberrant coagulation. Machine learning algorithms, particularly unsupervised clustering and deep learning-based computed tomography radiomics, have been investigated for more rapid phenotyping, but reported performance varies by task, cohort, and validation design. However, prospective, phenotype-guided randomized trials remain limited. Subphenotype stratification offers a mechanistically grounded framework for re-evaluating therapies that were ineffective in unselected populations and for investigating phenotype-informed ventilatory strategies. Clinical implementation requires standardized, bedside-compatible biomarker panels and definitive trials demonstrating that phenotype-specific interventions improve patient-centered outcomes.

Full article
Editorial Open Access
Sena Ardicli, Nursen Senturk, Huseyn Babayev
Published online September 20, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 965
Gene Expression. doi:10.14218/GE.2026.00006
Original Article Open Access
Rehman Shahab, Siyao Wang, Ahmad Faiza, Keyang Dong, Liping Zuo, Zhan Qu, Li Ma, Fangfang Li, S. Abdulaziz Abdulgani, Jing Li, Feng Ye, Yi Liu
Published online October 28, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 942
Journal of Translational Gastroenterology. doi:10.14218/JTG.2026.00031
Abstract
Pegylated interferon alpha (PegIFNα) has been associated with altered lipid metabolism, but long-term lipid trajectories in chronic hepatitis B remain poorly characterized. We evaluated [...] Read more.

Pegylated interferon alpha (PegIFNα) has been associated with altered lipid metabolism, but long-term lipid trajectories in chronic hepatitis B remain poorly characterized. We evaluated lipid profiles and virological parameters during 144 weeks of PegIFNα-based therapy.

This single-center retrospective cohort study included 129 patients with chronic hepatitis B who completed 144 weeks of PegIFNα monotherapy, PegIFNα plus tenofovir alafenamide, or PegIFNα plus entecavir. Serum lipids, hepatitis B surface antigen (HBsAg), hepatitis B e antigen, and hepatitis B virus DNA were assessed at baseline and weeks 24, 48, 72, 96, and 144. Within-patient changes were analyzed with paired tests. Associations between early lipid changes and on-treatment HBsAg seroclearance at week 144 were examined with logistic regression.

From baseline to week 144, mean high-density lipoprotein cholesterol (HDL-C) increased by 0.10 ± 0.25 mmol/L (95% confidence interval, 0.06 to 0.15; P < 0.001) and mean total cholesterol decreased by 0.15 ± 0.41 mmol/L (95% confidence interval, −0.22 to −0.08; P < 0.001). Changes in triglycerides, low-density lipoprotein cholesterol, and the triglyceride-to-HDL-C ratio were not significant. HDL-C declined early and later recovered above baseline. At week 144, 37 patients (28.7%) achieved on-treatment HBsAg seroclearance (≤ 0.05 IU/mL). Of the 34 patients with HBsAg seroclearance at week 96, 13 had detectable HBsAg again at week 144. Early lipid changes were not associated with this endpoint.

HDL-C shows an early decline followed by recovery above baseline, whereas total cholesterol decreases modestly, with no significant net changes in triglycerides, low-density lipoprotein cholesterol, or the triglyceride-to-HDL-C ratio. Early lipid changes are not significantly associated with on-treatment HBsAg seroclearance. The durability of HBsAg loss requires post-treatment follow-up.

Full article
Original Article Open Access
Andrey R. Karpenko, Anna V. Dorofeeva, Elizaveta R. Leonenko, Asiman Z. Agaeva, Ksenia A. Kobzeva, Vera A. Sergeeva, Olga Yu. Bushueva
Published online October 21, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 904
Gene Expression. doi:10.14218/GE.2026.00015
Abstract
A common feature of severe COVID-19 and two common metabolic comorbidities, type 2 diabetes mellitus (T2DM) and obesity, is a persistent inflammatory response. Heat shock proteins [...] Read more.

A common feature of severe COVID-19 and two common metabolic comorbidities, type 2 diabetes mellitus (T2DM) and obesity, is a persistent inflammatory response. Heat shock proteins (HSPs) are key regulators of cell proteostasis under stressful conditions, including inflammation, oxidative stress, hyperglycemia, and hyperlipidemia. The aim of the present study was to investigate associations between polymorphic variants in genes encoding HSPs and T2DM or obesity among patients with severe or critical COVID-19.

A total of 195 patients with severe or critical COVID-19 were included, of whom 39 had T2DM and 101 had obesity. T2DM and obesity were analyzed as separate, non-mutually-exclusive outcomes. Genotyping was performed using a TaqMan probe-based real-time polymerase chain reaction assay to detect single nucleotide polymorphisms (SNPs). Bioinformatics resources, including GTExPortal, eQTLGen, atSNP, and Gene Ontology, were used for functional annotation. Associations between HSP genetic variants and T2DM or obesity were analyzed. This study was conducted as a case-control analysis within a severe COVID-19 cohort and is reported in accordance with the STROBE guidelines.

Among patients with severe or critical COVID-19, SNP rs1043618 HSPA1A (odds ratio [OR] = 1.82, 95% confidence interval [CI] = 1.01–3.27, Pperm = 0.04), rs910652 HSPA12B (OR = 2.23, 95% CI = 1.18–4.21, Pperm = 0.01), and rs4926222 DNAJB1 (OR = 2.15, 95% CI = 1.08–4.27, Pperm = 0.03) were associated with higher odds of T2DM, whereas rs13161158 HSPA4 (OR = 0.11, 95% CI = 0.01–0.91, Pperm = 0.0075) and rs7189628 DNAJA2 (OR = 0.08, 95% CI = 0.01–0.65, Pperm = 0.001) were associated with lower odds of T2DM. In addition, SNP rs753856 HSPA6 (effect allele G) was associated with higher odds of obesity (OR = 2.11, 95% CI = 1.07–4.19, Pperm = 0.03).

Selected HSP SNPs are associated with T2DM or obesity among patients with severe or critical COVID-19. Functional annotation suggests plausible biological mechanisms, including cell proteostasis, inflammatory pathways, glucose metabolism, and adipogenic differentiation; however, independent and functional validation is required.

Full article
PrevPage 32 of 36 12…313233…3536Next
Back to Top